CHL1 gene acts as a tumor suppressor in human neuroblastoma-Reference-Cited by-同舟云学术

CHL1 gene acts as a tumor suppressor in human neuroblastoma

Published:2018-05-25 Issue:40 Volume:9 Page:25903-25921
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ognibene Marzia¹,Pagnan Gabriella²³,Marimpietri Danilo¹,Cangelosi Davide⁴,Cilli Michele⁵,Benedetti Maria Chiara⁶,Boldrini Renata⁶,Garaventa Alberto⁷,Frassoni Francesco¹,Eva Alessandra⁴,Varesio Luigi⁴,Pistoia Vito⁸,Pezzolo Annalisa¹

Affiliation:

1. Laboratorio Cellule Staminali Post Natali e Terapie Cellulari, Istituto Giannina Gaslini, Genova, Italy

2. Laboratorio di Oncologia, Istituto Giannina Gaslini, Genova, Italy

3. Present address: Laboratorio di Immunologia Clinica e Sperimentale, Istituto Giannina Gaslini, Genova, Italy

4. Laboratorio di Biologia Molecolare, Istituto Giannina Gaslini, Genova, Italy

5. Animal Model Facility, IRCCS Azienda Ospedaliera Universitaria San Martino, IST, Istituto per la Ricerca sul Cancro, Genova, Italy

6. Laboratorio di Anatomia Patologica, Ospedale Pediatrico Bambino Gesù, Roma, Italy

7. Divisione di Oncologia, Istituto Giannina Gaslini, Genova, Italy

8. Area di Immunologia, Ospedale Pediatrico Bambino Gesù, Roma, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastoma;Scientific Reports;2024-08-30

2. Transcriptome Profiling of Mouse Embryonic Fibroblast Spontaneous Immortalization: A Comparative Analysis;International Journal of Molecular Sciences;2024-07-25

3. CHL1 inhibits cell proliferation, migration and invasion by regulating the NF‑κB signaling pathway in colorectal cancer;Experimental and Therapeutic Medicine;2024-02-26

4. Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma;Frontiers in Immunology;2024-01-04

5. Computational intelligence analysis of high-risk neuroblastoma patient health records reveals time to maximum response as one of the most relevant factors for outcome prediction;European Journal of Cancer;2023-11